Ariel Miura

Analyst

Ariel Miura is an Analyst with Catalys Pacific. Prior to Catalys Pacific, she worked as a CMC scientist and US regulatory lead at Cellusion Inc., a Tokyo-based biotech focused on the development of iPS cell-derived corneal endothelial cell substitutes for bullous keratopathy patients. Before that, Ariel worked as a lab assistant/lab manager at the Harvard Medical School dep. of Otolaryngology within Mass. Eye and Ear, researching hearing regeneration via AAV gene therapy in various genetic hearing loss mouse models, and developing in vitro organoid models of the inner ear.

Ariel obtained her B.A. from Boston University with honors, double majoring in Psychology and Biology, with a concentration in Cell Biology, Molecular Biology and Genetics.

“Life’s most persistent and urgent question is, “What are you doing for others?".”

Martin Luther King Jr.

IKIGAI

I love learning about innovation and new technology, but I am most motivated by contributing to the development of real treatments to help real patients. I am very lucky that in this job, I get to engage with cutting-edge science while also making a tangible difference in people’s lives.